勘误-在模拟y位点给药过程中，头孢地罗与选定静脉注射药物的物理相容性。

Q4 Medicine

International journal of pharmaceutical compounding Pub Date : 2025-03-01

{"title":"勘误-在模拟y位点给药过程中，头孢地罗与选定静脉注射药物的物理相容性。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"In the article \"Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration,\" [Reference: Int J Pharm Compd. 2021; 25 (1): 52-61.] Table 1, row 33 states that the challenge drug was \"Total Parenteral Nutrition, Hospira (Lot 87-308-DK).\" This challenge drug description should be corrected to \"TPN Electrolytes, Hospira (Lot 87-308-DK).","PeriodicalId":14381,"journal":{"name":"International journal of pharmaceutical compounding","volume":"29 2","pages":"121"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the article \\\"Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration,\\\" [Reference: Int J Pharm Compd. 2021; 25 (1): 52-61.] Table 1, row 33 states that the challenge drug was \\\"Total Parenteral Nutrition, Hospira (Lot 87-308-DK).\\\" This challenge drug description should be corrected to \\\"TPN Electrolytes, Hospira (Lot 87-308-DK).\",\"PeriodicalId\":14381,\"journal\":{\"name\":\"International journal of pharmaceutical compounding\",\"volume\":\"29 2\",\"pages\":\"121\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of pharmaceutical compounding\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharmaceutical compounding","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在文章“模拟y位点给药过程中头孢地罗与选定静脉注射药物的物理相容性”中，[参考文献：Int J Pharm Compd. 2021；25(1): 52-61。表1第33行表明，挑战药物是“全肠外营养，Hospira （Lot 87-308-DK）”。该挑战药物描述应更正为“TPN电解质，Hospira （Lot 87-308-DK）”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.

In the article "Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration," [Reference: Int J Pharm Compd. 2021; 25 (1): 52-61.] Table 1, row 33 states that the challenge drug was "Total Parenteral Nutrition, Hospira (Lot 87-308-DK)." This challenge drug description should be corrected to "TPN Electrolytes, Hospira (Lot 87-308-DK).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International journal of pharmaceutical compounding Medicine-Medicine (all)

CiteScore

0.40

自引率

0.00%

发文量

期刊介绍： The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today"s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.